Business Description
Alphatec Holdings Inc
NAICS : 339112
SIC : 3841
ISIN : US02081G2012
Description
Alphatec Holdings Inc is a medical technology company focused on the designing, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.26 | |||||
| Equity-to-Asset | -0.11 | |||||
| Debt-to-Equity | -6.76 | |||||
| Debt-to-EBITDA | -11.07 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | -0.62 | |||||
| Beneish M-Score | -3.28 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 19.2 | |||||
| 3-Year EBITDA Growth Rate | 30.3 | |||||
| 3-Year EPS without NRI Growth Rate | 4.5 | |||||
| 3-Year FCF Growth Rate | 13.2 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 57.79 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 18.62 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 38.05 | |||||
| 9-Day RSI | 38.14 | |||||
| 14-Day RSI | 40.1 | |||||
| 3-1 Month Momentum % | 23.31 | |||||
| 6-1 Month Momentum % | 35.4 | |||||
| 12-1 Month Momentum % | 24.55 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.75 | |||||
| Quick Ratio | 1.67 | |||||
| Cash Ratio | 0.97 | |||||
| Days Inventory | 312.91 | |||||
| Days Sales Outstanding | 48.14 | |||||
| Days Payable | 104.14 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -13.1 | |||||
| Shareholder Yield % | -3.28 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 68.96 | |||||
| Operating Margin % | -18.12 | |||||
| Net Margin % | -25.77 | |||||
| EBITDA Margin % | -8.18 | |||||
| FCF Margin % | -12.83 | |||||
| ROA % | -21.5 | |||||
| ROIC % | -22.98 | |||||
| 3-Year ROIIC % | -7.5 | |||||
| ROC (Joel Greenblatt) % | -42.91 | |||||
| ROCE % | -22.68 | |||||
| Moat score | 4 | |||||
| Tariff score | 6 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 2.52 | |||||
| EV-to-EBIT | -14.67 | |||||
| EV-to-EBITDA | -38.57 | |||||
| EV-to-Revenue | 3.15 | |||||
| EV-to-Forward-Revenue | 2.76 | |||||
| EV-to-FCF | -24.59 | |||||
| Price-to-GF-Value | 0.79 | |||||
| Price-to-Median-PS-Value | 1.05 | |||||
| Earnings Yield (Greenblatt) % | -6.82 | |||||
| FCF Yield % | -5.14 |
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers